🎉 Wishing our readers, advertisers and collaborators a purposeful and prosperous 2026. Thank you for being part of our journey as we continue to inform, inspire and build impact together in the year ahead. 🎉 🎉 Wishing our readers, advertisers and collaborators a purposeful and prosperous 2026. Thank you for being part of our journey as we continue to inform, inspire and build impact together in the year ahead. 🎉
Sanofi buys Dynavax for $2.2 B to augment presence in adult immunisation sector

French biopharmaceutical firm Sanofi has entered into an agreement to acquire US-based Dynavax Technologies Corporation,...

December 26, 2025 | Friday | News
Australia's Vaxxas secures TGA approval to manufacture high-density microarray patch (HD-MAP)

Australian biotechnology pioneer Vaxxas Pty Ltd, has been granted a licence by the Therapeutic Goods Administration...

December 15, 2025 | Monday | News
Scientists in Korea to create mRNA vaccine against emerging tick-borne virus in Asia

Leading scientific organisations in Korea including the Korea Disease Control Agency (KDCA), International Vaccine Insti...

December 9, 2025 | Tuesday | News
CSL opens cell-based influenza vaccine and antivenom manufacturing facility in Melbourne

Australia’s onshore vaccine manufacturing capabilities took a leap forward as Mark Butler MP, Minister for Health,...

December 6, 2025 | Saturday | News
Japanese firms focus on developing cancer vaccines utilising whole-genome information

The Japanese Foundation for Cancer Research (JFCR), NEC Corporation, and Taiho Pharmaceutical Co. have signed a three-pa...

December 2, 2025 | Tuesday | News
Singapore's Patronus Biotech receives grant to evaluate novel malaria vaccine and adjuvant

Singapore-based startup Patronus Biotech has announced a grant from the Gates Foundation to accelerate the development o...

November 28, 2025 | Friday | News
Malaysia approves Sanofi and AstraZeneca's Beyfortus® (nirsevimab)

Sanofi and AstraZeneca's Beyfortus (Nirsevimab) is now approved (KKLIU 3697 / EXP 16.05.2026) by the National Pharmaceut...

November 24, 2025 | Monday | News
Singapore approves first needle-free flu vaccine FluMist Trivalent by AstraZeneca

A new intranasal influenza vaccine has been launched in Singapore, offering a needle-free option for individuals aged ...

November 19, 2025 | Wednesday | News
Apriori Bio and A*STAR ink strategic partnership to advance next generation influenza vaccines

US-based Apriori Bio and Singapore's Agency for Science, Technology and Research Infectious Diseases Labs (A*STAR IDL) h...

November 21, 2025 | Friday | News
Australia launches Biointelect Venturer for scientific innovators with $32.9 M funding

Australia’s new national incubator for vaccine and infectious disease innovation, Biointelect Venturer, has been l...

November 18, 2025 | Tuesday | News
The Zika Comeback: One Vaccine, One Hope

Nearly a decade after the world’s attention was gripped by the Zika virus outbreak in Brazil, the disease is quiet...

November 2, 2025 | Sunday | Opinion
Private Market Vaccines Drive Growth and Strategy Shifts Across China

HPV and PCV are the leading vaccines in the self-paid market in China. According to the WHO vaccine market report 2024, ...

November 1, 2025 | Saturday | Opinion
How Private Sector is Fueling APAC Vax Demand

The vaccine landscape in Asia-Pacific is undergoing significant transformation and growth. While public-sector programme...

November 1, 2025 | Saturday | Analysis
CSL Seqirus to localise advanced influenza vaccine manufacturing in Saudi Arabia

Australia-based CSL Seqirus and Vaccine Industrial Company have signed a Memorandum of Understanding with the Ministry o...

October 31, 2025 | Friday | News
CEPI, Serum Institute of India, Oxford University to establish world’s largest Nipah virus vaccine reserve

One of the world’s deadliest viral pathogens, Nipah virus, could soon have a new line of defence against it as Nor...

October 29, 2025 | Wednesday | News
Naobios and Tokyo Metropolitan Institute of Medical Science to develop new vaccine against mpox

France-based Naobios, a CDMO providing bioprocess development and GMP production of clinical batches of virus-based prod...

October 27, 2025 | Monday | News
Korea's GC Biopharma secures contract manufacturing rights for Shingles vaccine from Curevo

GC Biopharma, a South Korean biopharmaceutical company, has signed an agreement with Curevo Vaccine to secure contract m...

October 13, 2025 | Monday | News
Singapore researchers develop novel Nanovaccine to halt tumour growth and reduces cancer recurrence

Professor Shawn Chen Xiaoyuan, Nasrat Muzayyin Professor in Medicine and Technology from the Department of Dia...

September 24, 2025 | Wednesday | News